SecBot SecBot
Insider Cluster (4 insiders) ·Filed Jun 2, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago
Insider cluster: 4 insiders, $1.3M total
Actionable Insight • Neutral

Insider selling is routine and small relative to market cap. The CEO's option exercises and concurrent sales are standard liquidity/vesting activity. No bearish signal, monitor next earnings for fundamental trends.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$72.33
T+0 close · Jun 2, 2026 · via day close
Latest settled
+111.67%
T+60 · $153.10
Vs SPY
+109.17%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 3 $72.33entry
  2. T+1 · 6mo ago +2.21%α +1.81% · $73.93
  3. T+5 · 5mo ago −6.30%α −2.48% · $67.77
  4. T+20 · 5mo ago +37.20%α +38.20% · $99.24
  5. T+60 · 3mo ago +111.67%α +109.17% · $153.10
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, including the CEO (via option exercise and sale) and the CFO. The cluster is dominated by a single large sale by Cho Dennis ($991K), and the total represents ~0.03% of market cap, well below the 0.1% threshold for materiality. The CEO's sales are tied to derivative exercises, a common liquidity pattern. This is a routine, low-significance cluster.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
4

Key Facts

  • 4 insiders sold shares totaling $1.31M in open-market transactions over 7 days
  • Total sales represent ~0.03% of Twist's $4.2B market cap, trivial
  • CEO Leproust exercised 83,000 options at $8.82 and sold a portion of the resulting shares
  • CFO Laponis sold $280K; Director Starovasnik sold $170K; CAO Werner sold $50K
  • No insider open-market purchases were reported in the cluster

Financial Impact

Total insider sales of $1.31M represent ~0.03% of market cap, immaterial

dilutioninsider ownership

Risk Factors

  • Insider selling could accelerate if stock continues to rise, but current levels are not alarming
  • No insider buying to offset, lack of bullish insider conviction is neutral, not bearish

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1780430803897

US Market Status

Market Closed · Opens Wed (14h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026